Ingredion IncorporatedINGRNYSE
LOADING
|||

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
21 analysts·High coverage
43%
Rating Distribution
Strong Buy
00%
Buy
943%
Hold
1152%
Sell
15%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 12% higher.

Bear Case
$123.00
+7%
Consensus
$128.25
+12%
Bull Case
$136.00
+18%
Price Range21 analysts
Low
Consensus
High
$123.00
$136.00
Current Target
Current Price
$114.90
Upside to Target
$13.35

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Nov 6, 2025Industrial Alliance Securities
Ingredion downgraded to Equal Weight from Overweight at Barclays
Target:$124.00
+15.1%from $107.70
Nov 5, 2025BMO Capital
Ingredion price target lowered to $123 from $143 at BMO Capital
Target:$123.00
+14.9%from $107.02
Oct 22, 2025Oppenheimer
Ingredion price target lowered to $136 from $157 at Oppenheimer
Target:$136.00
+12.5%from $120.93
Oct 6, 2025UBS
Ingredion price target lowered to $130 from $144 at UBS
Target:$130.00
+8.0%from $120.42
Apr 22, 2025UBS
Ingredion price target lowered to $155 from $167 at Oppenheimer
Target:$155.00
+18.5%from $130.77
Apr 22, 2025Oppenheimer
Ingredion price target lowered to $155 from $167 at Oppenheimer
Target:$155.00
+18.5%from $130.77
Oct 21, 2024Oppenheimer
Ingredion (INGR) PT Raised to $147 at Oppenheimer
Target:$147.00
+9.6%from $134.12
Aug 9, 2024Barclays
Ingredion upgraded to Overweight from Equal Weight at Barclays
Target:$145.00
+14.4%from $126.76
Aug 7, 2024BMO Capital
Ingredion (INGR) PT Raised to $128 at BMO Capital
Target:$128.00
+1.3%from $126.37
Aug 7, 2024Oppenheimer
Ingredion (INGR) PT Raised to $138 at Oppenheimer
Target:$138.00
+9.2%from $126.37
May 9, 2024BMO Capital
Ingredion (INGR) PT Raised to $120 at BMO Capital
Target:$120.00
+1.6%from $118.09
May 8, 2024Oppenheimer
Ingredion (INGR) PT Raised to $126 at Oppenheimer
Target:$126.00
+6.4%from $118.45
Feb 15, 2024Goldman Sachs
Goldman Sachs Upgrades Ingredion (INGR) to Buy, 'rising balance sheet optionality'
Target:$135.00
+17.5%from $114.91
Sep 29, 2023Oppenheimer
Ingredion's Growth Strategy To Please Health-Conscious Consumers Can Make It A Winner: Analyst
Target:$120.00
+21.9%from $98.46